to 24 million units, combining both bottle and can formats. The company believed that China is a strategic country which will drive export sales in the future. Sales from Afghanistan and Yemen amounted
to 24 million units, combining both bottle and can formats. The company believed that China is a strategic country which will drive export sales in the future. Sales from Afghanistan and Yemen amounted
, and 1,722.70 million baht for year 2016, 2017, and 2018 respectively. As can be seen, the revenue from sale increased continuously every year. In the year 2018, increased orders and the market expansion
subsidiaries have the revenues from medical treatment of 796.27 million baht, which is a 0.15 % increase from the previous year. The revenues can from the two hospitals are broken down as follows
revenues from medical treatment of 3,621.15 million baht, which is a 6.42 % increase from the previous year. The revenues can from the three hospitals are broken down as follows : - Ramkhamhaeng Hospital
subsidiaries have the revenues from medical treatment of 855.83 million baht, which is a 7.51 % increase from the previous year. The revenues can from the two hospitals are broken down as follows
well received by our customers, in order to increase new customers and maintain our existing customer base. The Company is still working on plan and can achieve goals The number of “Boonterm Kiosk” in
subsidiaries have the revenues from medical treatment of 977.49 million baht, which is a 3.13 % increase from the previous year. The revenues can from the three hospitals are broken down as follows
associated company can decrease the cost from this investment. From this joint investment, Thippayabadin Company Limited can growth in revenue and profit. So, Ramkhamhaeng will receive benefit come back in
revenue a lot in Consolidated Financial Statement. The revenues can from the four hospitals are broken down as follows : - Ramkhamhaeng Hospital 1,089.94 million baht - Vibharam Hospital 1,045.09